Quoin Pharmaceuticals earnings were -$18.7M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest QNRX earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$5.4M, up 7.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, QNRX reported annual earnings of -$15.8M, with 76.3% growth. The next QNRX earnings date is Nov 5, 2026.
Quoin Pharmaceuticals Earnings Reports & History FAQ
What were Quoin Pharmaceuticals's earnings last quarter?
On QNRX's earnings call on Aug 14, 2026, Quoin Pharmaceuticals (NASDAQ: QNRX) reported Q2 2026 earnings per share (EPS) of N/A, up N/A year over year. Total QNRX earnings for the quarter were -$5.37 million. In the same quarter last year, Quoin Pharmaceuticals's earnings per share (EPS) was N/A.
The next QNRX earnings call is Nov 5, 2026. Add QNRX to your watchlist to be reminded of Quoin Pharmaceuticals's next earnings date.
Is Quoin Pharmaceuticals profitable or losing money?
As of the last Quoin Pharmaceuticals earnings report, Quoin Pharmaceuticals is currently losing money. Quoin Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$18.67 million, a 53.38% increase year over year.
What was QNRX's earnings growth in the past year?
As of Quoin Pharmaceuticals's earnings date in Aug 14, 2026, Quoin Pharmaceuticals's earnings has grown year over year. QNRX earnings in the past year totalled -$18.67 million.
What are Quoin Pharmaceuticals's earnings expectations?
The current EPS estimate for Quoin Pharmaceuticals's earnings report in Nov 5, 2026 is -$1.88.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.